Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A phase II, randomized, multicentre, observer-blind study to compare and characterize the immunoginicity and safety parameters induced by various GSK Biologicals’ Adjuvant Systems in combination with the Hepatitis B surface antigen (HBsAg), according to a 0, 1 month schedule with a booster at Month 12, in healthy, Hepatitis B virus (HBV) naïve, adults https://kusajili.com:443/Trial/PvhRboRwVU-gzCVOl5qtWw%24a-phase-ii-randomized-multicentre-observer-blind-study-to-compare-and-characterize-the-immunoginicity-and-safety-parameters-ind
I have read and accept the terms of use of the site and the Privacy Policy
Send your message